# Replimune Group, Inc.: Form 8-K, filed Jan 10, 2020

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2020-01-10
- Accepted by EDGAR: Jan 10, 2020, 08:45 ET
- Period: 2020-01-08
- Accession: 0001104659-20-002849
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465920002849/tm201777d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465920002849/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465920002849/tm201777d1_8k.htm

Filed Jan 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-002849. Last ingested by Listed: Nov 7, 2026, 12:41 ET. No prices; not investment advice.